Publications by authors named "Hroyuki Kuwano"
J Infect Chemother
December 2020
Article Synopsis
- Most COVID-19 patients experience mild symptoms, but about 5% face severe cases; ECMO is used for those critically ill, but it's not the primary treatment.
- A case study details a 54-year-old man who began showing symptoms on day 6 and required intubation and ECMO as his condition worsened.
- The medical team monitored his viral load, which dropped significantly, leading them to continue ECMO after issues arose, ultimately improving his respiratory status and stopping ECMO after 21 days.
